Immunotherapy following chemotherapy offers extended survival to patients with advanced urothelial cancer

'Study shows the largest survival benefit seen to date in advanced urothelial cancer,' said ASCO President Howard Burris

Join OnMedica and benefit from:

  • Bitesize CPD and easy to digest content, free for UK-based GPs and specialist doctors
  • High-quality, evidence-based content developed by expert editors and clinicians
  • Articles, quizzes, videos, visual summaries and more
  • Regulatory alerts and round-up of medical journals
  • New content added daily, so you know you’re always up to date

Existing members Sign in